Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038255 · ClinicalTrials.gov registry record · Phase 4
Mindfulness Based Smoking Cessation Among Cancer Survivors
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04038255 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 20 participants.
The verdict
NCT04038255, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
Interventions
- DRUG Nicoderm C-Q Transdermal Product
- BEHAVIORAL Orientation session
- BEHAVIORAL Craving-to-Quit app
- BEHAVIORAL Two brief follow-up phone calls
- BEHAVIORAL Group MT sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-28 |
| Est. Completion | 2024-05-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04038255
The ClinicalTrials.gov registry entry for NCT04038255 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nicoderm C-Q Transdermal Product is the first listed.
NCT04038255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04038255 about?
NCT04038255 is a clinical study titled "Mindfulness Based Smoking Cessation Among Cancer Survivors". This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors.
What is the current status of trial NCT04038255?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2019-09-28. Estimated completion is 2024-05-19.
What interventions are being tested in trial NCT04038255?
The interventions under investigation include: Nicoderm C-Q Transdermal Product (DRUG), Orientation session (BEHAVIORAL), Craving-to-Quit app (BEHAVIORAL), Two brief follow-up phone calls (BEHAVIORAL), Group MT sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04038255?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.